Unknown

Dataset Information

0

Geno2pheno[ngs-freq]: a genotypic interpretation system for identifying viral drug resistance using next-generation sequencing data.


ABSTRACT: Identifying resistance to antiretroviral drugs is crucial for ensuring the successful treatment of patients infected with viruses such as human immunodeficiency virus (HIV) or hepatitis C virus (HCV). In contrast to Sanger sequencing, next-generation sequencing (NGS) can detect resistance mutations in minority populations. Thus, genotypic resistance testing based on NGS data can offer novel, treatment-relevant insights. Since existing web services for analyzing resistance in NGS samples are subject to long processing times and follow strictly rules-based approaches, we developed geno2pheno[ngs-freq], a web service for rapidly identifying drug resistance in HIV-1 and HCV samples. By relying on frequency files that provide the read counts of nucleotides or codons along a viral genome, the time-intensive step of processing raw NGS data is eliminated. Once a frequency file has been uploaded, consensus sequences are generated for a set of user-defined prevalence cutoffs, such that the constructed sequences contain only those nucleotides whose codon prevalence exceeds a given cutoff. After locally aligning the sequences to a set of references, resistance is predicted using the well-established approaches of geno2pheno[resistance] and geno2pheno[hcv]. geno2pheno[ngs-freq] can assist clinical decision making by enabling users to explore resistance in viral populations with different abundances and is freely available at http://ngs.geno2pheno.org.

SUBMITTER: Doring M 

PROVIDER: S-EPMC6031006 | biostudies-literature | 2018 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

geno2pheno[ngs-freq]: a genotypic interpretation system for identifying viral drug resistance using next-generation sequencing data.

Döring Matthias M   Büch Joachim J   Friedrich Georg G   Pironti Alejandro A   Kalaghatgi Prabhav P   Knops Elena E   Heger Eva E   Obermeier Martin M   Däumer Martin M   Thielen Alexander A   Kaiser Rolf R   Lengauer Thomas T   Pfeifer Nico N  

Nucleic acids research 20180701 W1


Identifying resistance to antiretroviral drugs is crucial for ensuring the successful treatment of patients infected with viruses such as human immunodeficiency virus (HIV) or hepatitis C virus (HCV). In contrast to Sanger sequencing, next-generation sequencing (NGS) can detect resistance mutations in minority populations. Thus, genotypic resistance testing based on NGS data can offer novel, treatment-relevant insights. Since existing web services for analyzing resistance in NGS samples are subj  ...[more]

Similar Datasets

| S-EPMC8332578 | biostudies-literature
| S-EPMC3633008 | biostudies-literature
| S-EPMC3633056 | biostudies-literature
| S-EPMC10221606 | biostudies-literature
| S-EPMC6988211 | biostudies-literature
| S-EPMC6288784 | biostudies-other
| S-EPMC4431973 | biostudies-literature
| S-EPMC3631804 | biostudies-literature
| S-EPMC3708773 | biostudies-literature
2017-04-03 | PXD003804 | Pride